Profits down as MorphoSys invests in proprietary development
This article was originally published in Scrip
Executive Summary
MorphoSys' net profits dropped by 32% to €9.0 million for the year ending December 31st, 2009, owing to increased R&D costs. Revenues grew by 13% to €81.0 million.